0001601292-22-000003.txt : 20221101 0001601292-22-000003.hdr.sgml : 20221101 20221101162211 ACCESSION NUMBER: 0001601292-22-000003 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20221101 DATE AS OF CHANGE: 20221101 EFFECTIVENESS DATE: 20221101 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Embolx, Inc. CENTRAL INDEX KEY: 0001601292 IRS NUMBER: 300790974 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-463522 FILM NUMBER: 221350537 BUSINESS ADDRESS: STREET 1: 530 LAKESIDE DRIVE STREET 2: SUITE 200 CITY: SUNNYVALE STATE: CA ZIP: 94085 BUSINESS PHONE: 408-990-2949 MAIL ADDRESS: STREET 1: 530 LAKESIDE DRIVE STREET 2: SUITE 200 CITY: SUNNYVALE STATE: CA ZIP: 94085 D 1 primary_doc.xml X0708 D LIVE 0001601292 Embolx, Inc. 530 LAKESIDE DRIVE SUITE 200 SUNNYVALE CA CALIFORNIA 94085 408-990-2949 CALIFORNIA None None Corporation true MICHAEL ALLEN 530 Lakeside Drive Suite 200 Sunnyvale CA CALIFORNIA 94085 Executive Officer Director President & Chief Executive Officer MICHAEL LIN 530 Lakeside Drive Suite 200 Sunnyvale CA CALIFORNIA 94085 Executive Officer Director of Finance TOM BRETON 530 Lakeside Drive Suite 200 Sunnyvale CA CALIFORNIA 94085 Executive Officer Manager of Research & Development NORMAN GITIS 530 Lakeside Drive Suite 200 Sunnyvale CA CALIFORNIA 94085 Director FRANK GRILLO 530 Lakeside Drive Suite 200 Sunnyvale CA CALIFORNIA 94085 Director PAUL ROGAN 530 Lakeside Drive Suite 200 Sunnyvale CA CALIFORNIA 94085 Director TIANHONG XU 530 Lakeside Drive Suite 200 Sunnyvale CA CALIFORNIA 94085 Director Other Decline to Disclose 06b false 2022-10-19 false true true false 0 Revere Securities LLC 14178 None None 650 5th Avenue 35th Floor New York NY NEW YORK 10019 CA CALIFORNIA FL FLORIDA MA MASSACHUSETTS false 1629000 1629000 0 false 5 130320 true 0 true 0 true false Embolx, Inc. /s/ Michael Allen Michael Allen President and Chief Executive Officer 2022-11-01